Billionaire Profile
Otto Boehringer
Global Rank
#610

Image: Fritz Rehm (1871-1928) | Public domain | via Wikimedia Commons

Otto Boehringer

CEO, Pharmaceuticals
GERMANY
Real-Time Net Worth
$6.506B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
0% (24h)
Age
95
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
GERMANY

Biography

Otto Boehringer, at 95 years old, derives his wealth from the pharmaceutical industry. His fortune stems from his family's ownership of Boehringer Ingelheim, a leading, privately-owned pharmaceutical company. With a career spanning decades, Boehringer has witnessed the evolution of the pharmaceutical landscape, contributing significantly to the healthcare industry. His success reflects strategic foresight and a commitment to innovation, as Boehringer Ingelheim continues to develop and market groundbreaking medicines.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Details regarding Otto Boehringer's early life are not widely available in the public domain. However, his family's history is well-documented. Boehringer Ingelheim was founded in 1885 by Albert Boehringer in Ingelheim am Rhein, Germany. The company started as a small factory producing tartaric acid salts for the food industry and has since grown into a global pharmaceutical leader.

Rise to Success

Otto Boehringer's rise to success is intertwined with the growth of Boehringer Ingelheim. The company's expansion and success can be attributed to its focus on research and development, leading to the creation of innovative medicines. The company's expansion to the US market in the 1970s played a significant role.

Key Business Strategies

Boehringer Ingelheim's key business strategies include a strong emphasis on research and development, with a substantial investment in the development of new medicinal products. The company also focuses on innovation in various therapeutic areas, including cardiovascular, respiratory, oncology, and animal health. The company’s family ownership structure has ensured its long-term vision and commitment to innovation.

Philanthropy

Information regarding Otto Boehringer's specific philanthropic activities is not readily available. Boehringer Ingelheim, as a company, is committed to being a responsible corporate citizen.